Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell microarrays in drug discovery.

David Castel1, Amandine Pitaval, Marie-Anne Debily

  • 1CEA, DSV, DRR, Service de Génomique Fonctionnelle, 2 rue Gaston Crémieux-CP 22, 91057 Evry Cedex, France.

Drug Discovery Today
|June 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial.

Nature medicine·2026
Same author

Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered.

Acta neuropathologica communications·2026
Same author

Using vascularized organoids-on-chip for assessing systemic drug delivery.

Methods in cell biology·2026
Same author

H3K27ME3 loss in diffuse midline gliomas lacking H3K27M or EZHIP expressions, a potential diagnostic pitfall!

Acta neuropathologica·2026
Same author

Vascularizing organoids-on-chip for perfused and personalized models.

Lab on a chip·2026
Same author

Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Cell microarrays offer a promising approach for high-throughput screening (HTS) in drug discovery. This technology enhances the efficiency and cost-effectiveness of analyzing cellular responses to various perturbations.

Area of Science:

  • Cell biology
  • Biotechnology
  • Drug discovery

Background:

  • Systematic cell-based assays are crucial for understanding drug and gene effects.
  • High-throughput screening (HTS) requires efficient methods for analyzing cellular phenotypes.
  • Advancements in microtechnology enable new cell-based analysis platforms.

Purpose of the Study:

  • To compare different cell microarray approaches.
  • To evaluate the utility of cell microarrays in drug discovery.
  • To assess the potential of cell microarrays for high-throughput screening.

Main Methods:

  • Review and comparison of various cell microarray techniques.
  • Evaluation of cell microarray applications in metazoan cell research.
  • Analysis of efficiency and cost-effectiveness in cell-based HTS.

Related Experiment Videos

Main Results:

  • Cell microarrays are an emerging technology with significant potential.
  • This technology facilitates systematic analysis of cellular phenotypes.
  • Cell microarrays can optimize the efficiency:cost ratio in cell-based HTS.

Conclusions:

  • Cell microarrays show great promise for drug discovery.
  • The technology offers an improved approach to cell-based HTS.
  • Cell microarrays are a valuable tool for analyzing cellular responses.